US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ecopetrol SA

7.88

+0.0000

Pre-market: 7.980.1000+1.27%08:27 EDT

Volume:3.26M

Turnover:25.76M

Market Cap:16.20B

PE:4.78

High:8.03

Open:7.97

Low:7.83

Close:7.88

Loading ...

Overview Company News Filings

European Commission Approves Subcutaneous RYBREVANT® (amivantamab) Co-Formulated with ENHANZE® for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer

Corcept Initiates Trial of Relacorilant Plus Nab-Paclitaxel and Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer

TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals

Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction in Patients (N=120) with Acquired Hypothalamic Obesity

Pharvaris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Let large families buy new HDB 3Gen flats and enjoy priority for 4- and 5-bedder exec condos

Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients with Acquired Hypothalamic Obesity

Analysts Offer Insights on Energy Companies: Ecopetrol SA (EC) and Gulfport Energy (GPOR)

Akebia Therapeutics Announces Positive Opinion of European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease Licensed to Averoa

Ecopetrol (EC) Rises But Trails Market: What Investors Should Know

Market Chatter: Ecopetrol Mulls Buying SierraCol Energy From Carlyle Group

MT Newswires Live

Pharvaris says EC grants orphan designation to deucrictibant

Pharvaris Announces Orphan Designation Granted to Deucrictibant by the European Commission

The European Commission refers lecanemab decision to Appeal Committee

European Commission Approves Pfizer’s RSV Vaccine ABRYSVO® to Help Protect Adults Aged 18-59 Against RSV Lower Respiratory Tract Disease

Press Release: ESS Tech, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

Singapore’s private home price index eases to 0.6% in Q1: URA flash data

TIVDAK® (tisotumab vedotin) Approved by European Commission for Previously Treated Recurrent or Metastatic Cervical Cancer

Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/EC/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EC\",,,,,undefined,":{"symbol":"EC","market":"US","secType":"STK","nameCN":"Ecopetrol SA","latestPrice":7.88,"timestamp":1746561600000,"preClose":7.88,"halted":0,"volume":3256186,"hourTrading":{"tag":"盘前","latestPrice":7.98,"preClose":7.88,"latestTime":"08:27 EDT","volume":3934,"amount":31496.201968,"timestamp":1746620833679},"delay":0,"floatShares":233420503,"shares":2055834734,"eps":1.647439,"marketStatus":"Pre-Mkt","change":0,"latestTime":"05-07 08:29:38 EDT","open":7.97,"high":8.03,"low":7.825,"amount":25764685.69151,"amplitude":0.026015,"askPrice":8.05,"askSize":327,"bidPrice":7.96,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":1.647439,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746624600000},"marketStatusCode":1,"adr":1,"adrRate":20,"listingDate":1221710400000,"exchange":"NYSE","adjPreClose":7.88,"preHourTrading":{"tag":"盘前","latestPrice":7.98,"preClose":7.88,"latestTime":"08:27 EDT","volume":3934,"amount":31496.201968,"timestamp":1746620833679},"postHourTrading":{"tag":"盘后","latestPrice":7.95,"preClose":7.88,"latestTime":"19:56 EDT","volume":21491,"amount":169660.2226,"timestamp":1746575803813},"volumeRatio":1.0266731215319211,"impliedVol":0.5394,"impliedVolPercentile":0.6787},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EC\",,,,,undefined,":{"symbol":"EC","floatShares":233420503,"roa":"8.01%","roe":"18.41%","lyrEps":1.647439,"volumeRatio":1.0266731215319211,"shares":2055834734,"dividePrice":1.65929,"high":8.03,"amplitude":0.026015,"preClose":7.88,"low":7.825,"week52Low":7.21,"pbRate":"0.80","psRate":"0.50","week52High":12.67,"institutionHeld":0,"latestPrice":7.88,"committee":0.718951,"eps":1.647439,"divideRate":0.21057,"volume":3256186,"delay":0,"ttmEps":1.647439,"open":7.97,"prevYearClose":7.92,"prevWeekClose":8.15,"prevMonthClose":8.11,"prevQuarterClose":10.44,"fiveDayClose":8.3,"twentyDayClose":8.83,"sixtyDayClose":9.67},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EC\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2525466100","title":"European Commission Approves Subcutaneous RYBREVANT® (amivantamab) Co-Formulated with ENHANZE® for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2525466100","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525466100?lang=en_us&edition=fundamental","pubTime":"2025-04-07 21:25","pubTimestamp":1744032300,"startTime":"0","endTime":"0","summary":"SAN DIEGO, April 7, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc.   today announced that Janssen-Cilag International NV, a Johnson & Johnson company, has received European Commission  marketing authorization ofthe subcutaneous  formulation of RYBREVANT , in combination withLAZCLUZE , for the first-line treatment of adult patients with advanced non-small cell lung cancer  with epidermal growth factor receptor  exon19 deletions or exon 21 L858R substitution mutations. Additionally, it is approved as amonotherapy for adult patients with advanced NSCLC with activating EGFR exon 20 insertion mutations after the failure of platinum-based therapy.Subcutaneous amivantamab is co-formulated Halozyme's ENHANZE drug delivery technology.Halozyme also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies that are designed to provide commercial or functional advantages such as improved convenience, rel","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/european-commission-approves-subcutaneous-rybrevant-132500621.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/european-commission-approves-subcutaneous-rybrevant-132500621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HALO","LU0053671581.USD","BK4139","IE00B66KJ199.SGD","IE00B7SZL793.SGD","AEIS","EC","IE00B19Z4B17.USD","BK4157","BK4201","IE0031619046.USD"],"gpt_icon":0},{"id":"2525704880","title":"Corcept Initiates Trial of Relacorilant Plus Nab-Paclitaxel and Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2525704880","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525704880?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:00","pubTimestamp":1744027200,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., April 07, 2025----Corcept Therapeutics Incorporated , a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced the start of BELLA, a Phase 2 trial of relacorilant plus nab-paclitaxel and bevacizumab evaluating efficacy and safety in patients with platinum-resistant ovarian cancer.BELLA is a single-arm, open-label trial with a planned enrollment of 90 women with recurrent, platinum-resistant ovarian cancer at approximately 50 sites in North America, Europe and Asia-Pacific. Patients will receive relacorilant in combination with nab-paclitaxel and bevacizumab.\"In our pivotal Phase 3 ROSELLA trial, treatment with relacorilant and nab-paclitaxel improved patients’ progression-free and overall survival, without increasing their side effect burden,\" said Bill Guyer, PharmD, Corcept’s Chief Development ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/corcept-initiates-trial-relacorilant-plus-120000565.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EC","LU0566484027.USD","BK4201","LU1559883803.SGD","CORT","BK4532","BK4007"],"gpt_icon":0},{"id":"2525141570","title":"TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals","url":"https://stock-news.laohu8.com/highlight/detail?id=2525141570","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525141570?lang=en_us&edition=fundamental","pubTime":"2025-04-07 19:30","pubTimestamp":1744025400,"startTime":"0","endTime":"0","summary":"NEW YORK, April  07, 2025  (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the publication of two journal articles one describing the evolution of CD20 treatments for multiple","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/07/3056593/8790/en/TG-Therapeutics-Announces-Two-Publications-Highlighting-BRIUMVI-in-Medical-Journals.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051017.SGD","LU0106831901.USD","LU2089284900.SGD","BK4153","LU0225283273.USD","LU0320765646.SGD","BK4139","BK4581","LU0006306889.USD","BK4588","LU2111349929.HKD","BK4127","LU1989772840.SGD","LU2347655156.SGD","BK4504","IE00BZ1G4Q59.USD","LU1720051108.HKD","LU1668664300.SGD","LU1732799900.SGD","LU0971096721.USD","LU2028103732.USD","LU0158827948.USD","BK4135","TGTX","BK4585","PML","LU1363072403.SGD","EC","LU0795875086.SGD","LU1162221912.USD","LU0158827781.USD","LU1548497426.USD","CNS","LU2089283258.USD","LU0098860793.USD","IE00BKVL7J92.USD","LU0314104364.USD","LU0267386448.USD","LU0795875169.SGD","BK4201","LU1074936037.SGD","LU0106261372.USD","LU1989772923.USD","BK4090","TG","LU1732800096.USD","LU2357305700.SGD","BK4534","LU2271345857.HKD","BK4516"],"gpt_icon":0},{"id":"2525118940","title":"Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction in Patients (N=120) with Acquired Hypothalamic Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2525118940","media":"GlobeNewswire","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525118940?lang=en_us&edition=fundamental","pubTime":"2025-04-07 19:00","pubTimestamp":1744023600,"startTime":"0","endTime":"0","summary":"-- Patients with acquired hypothalamic obesity on setmelanotide therapy (n=81) achieved mean BMI change of -16.5% compared with +3.3% for placebo (n=39) at 52 weeks (p<0.0001) -- -- -19.2% placebo-adj","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/07/3056552/0/en/Rhythm-Pharmaceuticals-Announces-Pivotal-Phase-3-TRANSCEND-Trial-Meets-Primary-Endpoint-with-19-8-Placebo-adjusted-BMI-Reduction-in-Patients-N-120-with-Acquired-Hypothalamic-Obesit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMI","BK4157","EC","BK4201"],"gpt_icon":0},{"id":"2525019961","title":"Pharvaris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2525019961","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525019961?lang=en_us&edition=fundamental","pubTime":"2025-04-07 18:58","pubTimestamp":1744023480,"startTime":"0","endTime":"0","summary":"Target enrollment achieved in RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, strengthening confidence in clinical timelinesEnrollment underway in CHAPTE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/07/3056547/0/en/Pharvaris-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","LU0205194284.USD","LU1169590202.USD","BK4198","IE00B64QTZ34.USD","LU0012050646.USD","BK4201","LU0106261612.USD","LU0205193047.USD","LU1169589451.USD","IE00BLDYK493.USD","HAE"],"gpt_icon":0},{"id":"2525069610","title":"Let large families buy new HDB 3Gen flats and enjoy priority for 4- and 5-bedder exec condos","url":"https://stock-news.laohu8.com/highlight/detail?id=2525069610","media":"businesstimes","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525069610?lang=en_us&edition=fundamental","pubTime":"2025-04-07 05:55","pubTimestamp":1743976556,"startTime":"0","endTime":"0","summary":"Apart from financial incentives, housing policy changes can help support families with three children or more","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"bustime_highlight","url":"https://www.businesstimes.com.sg/opinion-features/let-large-families-buy-new-hdb-3gen-flats-and-enjoy-priority-4-and-5-bedder-exec-condos","rn_cache_url":null,"customStyle":"","selectors":"body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businesstimes.com.sg/opinion-features/let-large-families-buy-new-hdb-3gen-flats-and-enjoy-priority-4-and-5-bedder-exec-condos","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bustime_highlight","symbols":["SG9999014005.SGD","SG9999014021.USD","EC","LU2226246903.HKD","LU0287143357.SGD","LU1854104046.USD","BK6520","LU0797268264.HKD","LU0197229882.USD","LU0348744763.USD","LU1105468828.SGD","LU0536402901.SGD","5OC.SI","BK4207","LU0918141705.HKD","LU0541502299.USD","BK4566","LU0630378692.HKD","LU1791710582.SGD","LU1854103824.USD","LU1267930656.SGD","LU2265009873.SGD","BK4535","LU1282648689.USD","LU0528227936.USD","LU1804176565.USD","SG9999014013.SGD","LU0348814723.USD","LU0390134368.USD","LU0708995666.HKD","LU0348816934.USD","LU0197773160.USD","LU0197773673.USD","BK4585","BTO","LU0231203729.USD","LU1805238398.USD","LU0868486357.SGD","LU2279701549.SGD","CFA.SI","BK4201","LU0456842615.SGD","LU0541501648.USD","LU2008162690.USD","BK4523","LU2177674079.SGD","BK6045","LU0431992006.USD","LU0630378429.USD","HDB"],"gpt_icon":0},{"id":"2525069417","title":"Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients with Acquired Hypothalamic Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2525069417","media":"GlobeNewswire","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525069417?lang=en_us&edition=fundamental","pubTime":"2025-04-07 00:00","pubTimestamp":1743955200,"startTime":"0","endTime":"0","summary":"Company to host conference call on April 7 at 8 a.m. ET. BOSTON, April 06, 2025  -- Rhythm Pharmaceuticals, Inc. , a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced the Company will hold a conference call and webcast on Monday, April 7, 2025 at 8:00 a.m. ET to disclose topline results from the Pivotal Phase 3 TRANSCEND trial evaluating setmelanotide, a melanocortin-4 receptor  agonist, in patients with acquired hypothalamic obesity.Setmelanotide IndicationInthe United States, setmelanotide is indicated to reduce excess body weight and maintain weight reduction long term in adult and pediatric patients aged 2 year","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rhythm-pharmaceuticals-announce-topline-results-160000427.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EC","RYTM","BK4139","BK4585","BK4201","BK4588","BK4157","BMI"],"gpt_icon":0},{"id":"2524299602","title":"Analysts Offer Insights on Energy Companies: Ecopetrol SA (EC) and Gulfport Energy (GPOR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524299602","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524299602?lang=en_us&edition=fundamental","pubTime":"2025-04-04 01:20","pubTimestamp":1743700808,"startTime":"0","endTime":"0","summary":"Companies in the Energy sector have received a lot of coverage today as analysts weigh in on Ecopetrol SA (EC – Research Report) and Gulfport Energ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-energy-companies-ecopetrol-sa-ec-and-gulfport-energy-gpor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-energy-companies-ecopetrol-sa-ec-and-gulfport-energy-gpor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GPOR","BK4213","EC","BK4201"],"gpt_icon":0},{"id":"2524725981","title":"Akebia Therapeutics Announces Positive Opinion of European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease Licensed to Averoa","url":"https://stock-news.laohu8.com/highlight/detail?id=2524725981","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524725981?lang=en_us&edition=fundamental","pubTime":"2025-04-03 20:00","pubTimestamp":1743681600,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., April 03, 2025  -- Akebia Therapeutics, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the Committee for Medicinal Products for Human Use  of the European Medicines Agency  has adopted a positive opinion recommending the European Commission  to approve XOANACYL  for the treatment of concomitant elevated serum phosphorous and iron deficiency in adult patients with chronic kidney disease .“We congratulate our partner Averoa on a positive step toward securing EMA approval for XOANACYL, and we will continue to support their efforts to deliver a treatment for complications of kidney disease to patients in Europe,” said John P. Butler, Chief Executive Officer of Akebia.The EC will review the CHMP recommendation, and a final decision is expected in approximately two months.About Akebia TherapeuticsAkebia Therapeutics, Inc.is a fully integrated biopharmaceutical company with the purpose to bet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/akebia-therapeutics-announces-positive-opinion-120000568.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4087","CHMP","AKBA","BK4201","MDCO","EC","BK4139"],"gpt_icon":0},{"id":"2524423451","title":"Ecopetrol (EC) Rises But Trails Market: What Investors Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2524423451","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524423451?lang=en_us&edition=fundamental","pubTime":"2025-04-03 05:50","pubTimestamp":1743630615,"startTime":"0","endTime":"0","summary":"Ecopetrol  closed the most recent trading day at $10.63, moving +0.19% from the previous trading session. The stock's performance was behind the S&P 500's daily gain of 0.67%. Elsewhere, the Dow gained 0.56%, while the tech-heavy Nasdaq added 0.87%.Shares of the oil and natural gas exploration company have appreciated by 16.47% over the course of the past month, outperforming the Oils-Energy sector's gain of 3.06% and the S&P 500's loss of 5.28%.The investment community will be closely monitoring the performance of Ecopetrol in its forthcoming earnings report. The company is predicted to post an EPS of $0.58, indicating a 16% growth compared to the equivalent quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $7.35 billion, showing a 7.89% drop compared to the year-ago quarter.It's also important for investors to be aware of any recent modifications to analyst estimates for Ecopetrol. These recent revisions tend to reflect the evolving nature of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ecopetrol-ec-rises-trails-market-215015228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4201","ISBC","BK4211","EC"],"gpt_icon":0},{"id":"2524437438","title":"Market Chatter: Ecopetrol Mulls Buying SierraCol Energy From Carlyle Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2524437438","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524437438?lang=en_us&edition=fundamental","pubTime":"2025-04-02 16:24","pubTimestamp":1743582257,"startTime":"0","endTime":"0","summary":"Ecopetrol  is considering acquiring Carlyle Group's  Colombian oil driller, SierraCol Energy, to boost reserves and output, Bloomberg reported late Tuesday, citing an interview with Ecopetrol executives.Reuters reported last month that Carlyle is looking to sell SierraCol for $1.5 billion, Bloomberg said.\"We were invited to the process and are currently analyzing the option,\" Rafael Guzman, Ecopetrol's vice president of hydrocarbons, told Bloomberg. \"We have yet to decide if we present an offer.Carlyle Group didn't immediately respond to MT Newswires' request for comment.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CG","BK4135","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","EC","BK4201"],"gpt_icon":0},{"id":"2524913194","title":"Pharvaris says EC grants orphan designation to deucrictibant","url":"https://stock-news.laohu8.com/highlight/detail?id=2524913194","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524913194?lang=en_us&edition=fundamental","pubTime":"2025-04-01 18:55","pubTimestamp":1743504949,"startTime":"0","endTime":"0","summary":"Pharvaris (PHVS) announced that the European Commission has granted orphan designation to its investigational drug, deucrictibant, for the treatmen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pharvaris-says-ec-grants-orphan-designation-to-deucrictibant?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pharvaris-says-ec-grants-orphan-designation-to-deucrictibant?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4201","BK4007","PHVS","EC"],"gpt_icon":0},{"id":"2524191187","title":"Pharvaris Announces Orphan Designation Granted to Deucrictibant by the European Commission","url":"https://stock-news.laohu8.com/highlight/detail?id=2524191187","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524191187?lang=en_us&edition=fundamental","pubTime":"2025-04-01 18:50","pubTimestamp":1743504600,"startTime":"0","endTime":"0","summary":"ZUG, Switzerland, April  01, 2025  (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/01/3053128/0/en/Pharvaris-Announces-Orphan-Designation-Granted-to-Deucrictibant-by-the-European-Commission.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","IE00BLDYK493.USD","LU1169589451.USD","LU0106261612.USD","LU0012050646.USD","LU0205194284.USD","BK4198","IE00B64QTZ34.USD","HAE","LU0205193047.USD","LU1169590202.USD","BK4201"],"gpt_icon":0},{"id":"2524219948","title":"The European Commission refers lecanemab decision to Appeal Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2524219948","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524219948?lang=en_us&edition=fundamental","pubTime":"2025-04-01 18:17","pubTimestamp":1743502620,"startTime":"0","endTime":"0","summary":"STOCKHOLM, April 1, 2025 /PRNewswire/ --BioArctic AB's   partner Eisai today announced that the European Commission  has decided to refer the marketing authorisation approval decision of lecanemab in the EU to the Appeal Committee.If the marketing authorization application for lecanemab is approved, the approval will apply to all 27 European Union member states, as well as Iceland, Liechtenstein, and Norway. Leqembi is already approved in the US, Japan, China, Great Britain and other markets.Lecanemab is approved in the U.S., Japan, China, United Kingdom, and several other markets for the treatment of mild cognitive impairment  due to Alzheimer's disease  and mild AD dementia. Lecanemab's approvals in these countries, as well as the CHMP's positive opinion in November 2024, were primarily based on Phase 3 data from Eisai's global Clarity AD clinical trial, in which it met its primary endpoint and all key secondary endpoints with statistically significant results. Eisai has also submitt","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/european-commission-refers-lecanemab-decision-101700021.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/european-commission-refers-lecanemab-decision-101700021.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CHMP","BRCTF","MAA","BK4215","BK4087","EC","MCI","BK4201","BK4588","BK4139","BK4585"],"gpt_icon":0},{"id":"2524016956","title":"European Commission Approves Pfizer’s RSV Vaccine ABRYSVO® to Help Protect Adults Aged 18-59 Against RSV Lower Respiratory Tract Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2524016956","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524016956?lang=en_us&edition=fundamental","pubTime":"2025-04-01 15:00","pubTimestamp":1743490800,"startTime":"0","endTime":"0","summary":"ABRYSVO is the first and only RSV vaccine approved in the European Union  for non-pregnant adults aged 18-49. NEW YORK, April 01, 2025----Pfizer Inc.  announced today that the European Commission  has issued a decision amending the marketing authorization for ABRYSVO, the company’s bivalent respiratory syncytial virus  prefusion F  vaccine, to extend the indication to include prevention of lower respiratory tract disease  caused by RSV in individuals 18 through 59 years of age. This expands the previous authorization for individuals aged 60 and older, and ABRYSVO now offers in the EU the broadest RSV vaccine indication, which includes:. Active immunization of individuals 18 years of age and older for the prevention of LRTD caused by RSV. ABOUT RSVRespiratory Syncytial Virus  is a contagious virus and a common cause of respiratory illness worldwide.5 The virus can affect the lungs and breathing passages of an infected individual, potentially causing severe illness or death.6,7,8 There a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b03cb07231ec101993964453ca7b8fef","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/european-commission-approves-pfizer-rsv-070000511.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4599","LU0122379950.USD","F","LU0306807586.USD","BK4585","LU0234572021.USD","EC","BK4555","BK4592","LU0321505868.SGD","LU0985481810.HKD","SG9999002232.USD","LU0170899867.USD","LU1883839398.USD","SG9999011175.SGD","LU0456855351.SGD","BK4516","BK4156","BK4588","LU0868494617.USD","SG9999001176.SGD","PFE","BK4099","IE000M9KFDE8.USD","BK4581","BK4574","IE00B19Z3581.USD","LU0225771236.USD","BK4533","LU0058720904.USD","BK4568","IE0002270589.USD","BK4087","LU1057294990.SGD","CHMP","BK4550","LU1894683264.USD","BK4534","SG9999002224.SGD","SG9999013999.USD","IE00BLSP4239.USD","BK4201","LU1066053197.SGD","LU0321505439.SGD","LU0289739699.SGD","LU1894683348.USD","SGXZ57979304.SGD","SG9999003800.SGD","BK4007"],"gpt_icon":1},{"id":"2524626974","title":"Press Release: ESS Tech, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2524626974","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524626974?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:05","pubTimestamp":1743451500,"startTime":"0","endTime":"0","summary":"Completed Commissioning and Grid Interconnection of First Two Energy Centers. Delivered Eight Energy Center Systems to Florida Utility. Achieved Breakeven Profitability on Energy Center Design at the end of Q4, Almost a Year Ahead of Schedule. Announced Energy Base, a New Modular, Non-Containerized Gigawatt-Hour scale LDES Solution. ESS Global Fleet Surpasses 2 GWh of Transacted Energy. ESS Tech, Inc.  , a leading manufacturer of iron flow long-duration energy storage  systems for commercial and utility-scale applications, today announced financial results for its fourth quarter and full year ended December 31, 2024.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","BK4215","BK4201","BK4585","BK6088","03160","BK4597","EC","5AL.SI","GWH","BK4588","ESS","BK4096","BK4604","BK4555","BK6522","BK4099"],"gpt_icon":0},{"id":"2524718809","title":"Singapore’s private home price index eases to 0.6% in Q1: URA flash data","url":"https://stock-news.laohu8.com/highlight/detail?id=2524718809","media":"businesstimes","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524718809?lang=en_us&edition=fundamental","pubTime":"2025-04-01 01:05","pubTimestamp":1743440706,"startTime":"0","endTime":"0","summary":"This follows a 2.3 per cent increase in Q4 last year, and a full-year price growth of 3.9 per cent in 2024","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"bustime_highlight","url":"https://www.businesstimes.com.sg/property/singapores-private-home-price-index-eases-0-6-q1-ura-flash-data","rn_cache_url":null,"customStyle":"","selectors":"body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businesstimes.com.sg/property/singapores-private-home-price-index-eases-0-6-q1-ura-flash-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bustime_highlight","symbols":["URA","EC","BK4606","BK4585","CFA.SI","BK4201","BK4588"],"gpt_icon":0},{"id":"2523092138","title":"TIVDAK® (tisotumab vedotin) Approved by European Commission for Previously Treated Recurrent or Metastatic Cervical Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2523092138","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523092138?lang=en_us&edition=fundamental","pubTime":"2025-03-31 23:20","pubTimestamp":1743434400,"startTime":"0","endTime":"0","summary":"Media Release COPENHAGEN, Denmark; March 31, 2025 TIVDAK is the first and only antibody-drug conjugate (ADC) approved to treat recurrent or metastatic cervical cancer with disease progression on or af","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/31/3052498/0/en/TIVDAK-tisotumab-vedotin-Approved-by-European-Commission-for-Previously-Treated-Recurrent-or-Metastatic-Cervical-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","LU1057294990.SGD","SG9999003800.SGD","IE00B19Z3B42.SGD","LU0234572021.USD","EC","ADC","BK4581","BK4097","LU0321505868.SGD","LU1066051498.USD","BK4585","LU0053666078.USD","LU0868494617.USD","MAA","LU1883839398.USD","PFS","BK4599","LU0122379950.USD","LU0225284248.USD","SG9999001176.USD","SG9999011175.SGD","IE00BLSP4452.SGD","BK4534","OS","SGXZ57979304.SGD","ORR","SG9999002224.SGD","BK4533","LU0289739699.SGD","LU0306806265.USD","LU0985481810.HKD","IE000M9KFDE8.USD","IE00B19Z3581.USD","IE0002270589.USD","IE00BBT3K403.USD","LU1894683264.USD","BK4007","BK4201","LU0058720904.USD","BK4550","SG9999013999.USD","BK4592","LU0170899867.USD","BK4107","BK4231","L","LU0321505439.SGD"],"gpt_icon":1},{"id":"2523946601","title":"Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2523946601","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523946601?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:00","pubTimestamp":1743422400,"startTime":"0","endTime":"0","summary":"Relacorilant plus nab-paclitaxel improved progression-free and overall survival and did not increase side effect burden. Results will support a New Drug Application  in the United States and a Marketing Authorization Application  in Europe. Relacorilant plus nab-paclitaxel has the potential to become a new standard of care for patients with platinum-resistant ovarian cancer. REDWOOD CITY, Calif., March 31, 2025----Corcept Therapeutics Incorporated , a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that ROSELLA, the company’s pivotal Phase 3 trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer, met its primary endpoint of improved progression-free survival, as assessed by blinded independent central review .\"Patients with advanced ovarian cancer have few good treatment op","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/primary-endpoint-met-corcept-pivotal-120000306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0566484027.USD","BK4588","EC","BK4215","LU1559883803.SGD","BK4097","BK4532","CORT","MAA","BK4585","BK4201","BK4007","OS"],"gpt_icon":0},{"id":"2522257316","title":"Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2522257316","media":"Business Wire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522257316?lang=en_us&edition=fundamental","pubTime":"2025-03-28 20:00","pubTimestamp":1743163200,"startTime":"0","endTime":"0","summary":"Recommendation is based primarily on results from the Phase 3 CheckMate -67T trial which demonstrated noninferiority in the co-primary endpoints of Cavgd28 and Cminss and consistent efficacy in the secondary endpoint of overall response rate for the subcutaneous formulation of Opdivo vs. its intravenous formulation. A decision on the EU Opdivo extension of marketing authorization is expected by June 2, 2025. \"The positive CHMP opinion is an important step forward in the evolution of immuno-oncology and in the potential of subcutaneous nivolumab to help transform the lives of people living with cancer,\" said Dana Walker, M.D., M.S.C.E., Opdivo global program lead, Bristol Myers Squibb. \"We look forward to bringing the same high-quality care that transformed cancer treatment with an administration method that has the potential to improve the patient experience and efficiency of healthcare systems in Europe.\"","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bristol-myers-squibb-receives-positive-120000105.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HSCT","IE00BFTCPJ56.SGD","LU1868836914.USD","BK4156","LU0882574055.USD","EEA","LU1670710588.SGD","LU0061475181.USD","EC","BK4585","LU0868494617.USD","BK4559","CHMP","CRT","LU1261432733.SGD","TEN","LU1718418525.SGD","LU1323610961.USD","LU1093756325.SGD","LU1074936037.SGD","LU1093756168.USD","LU2133065610.SGD","RCC","BK4534","LU1670710661.SGD","LU0237698245.USD","IE00BJJMRZ35.SGD","LU1291159041.SGD","ORR","IE0002141913.USD","LU0306807586.USD","VOD","LU0096364046.USD","LU0456855351.SGD","UK","BK4500","LU1032466523.USD","BK4007","LU1670711040.USD","LU2242652126.USD","MYE","ALK","BK4008","BMY","LU1670711123.USD","IE0009355771.USD","BK4528","LU0321505439.SGD","BK4532"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EC\",params:#limit:5,,,undefined,":[{"date":"2025-06-26","symbol":"EC","amount":0.5202,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-26","defaultRemindTime":1750944600000,"name":"哥伦比亚国家石油","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-26","currency":"USD","dateTimestamp":1750910400000,"payDate":"2025-07-07"},{"market":"US","date":"2025-05-06","symbol":"EC","fiscalQuarterEnding":"2025/03","expectedEps":0.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":0.5},{"date":"2025-04-28","symbol":"EC","amount":0.5202,"announcedDate":"2025-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-28","defaultRemindTime":1745847000000,"name":"哥伦比亚国家石油","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-06","payableDate":"2025-04-28","currency":"USD","dateTimestamp":1745812800000,"payDate":"2025-05-06"},{"date":"2025-04-03","symbol":"EC","amount":0.5202,"announcedDate":"2025-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-03","defaultRemindTime":1743687000000,"name":"哥伦比亚国家石油","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-11","payableDate":"2025-04-03","currency":"USD","dateTimestamp":1743652800000,"payDate":"2025-04-11"},{"market":"US","date":"2025-03-04","symbol":"EC","fiscalQuarterEnding":"2024/12","expectedEps":0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741064400000,"reportTimeType":"post","actualEps":0.74}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EC\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-17","recordDate":"2015-06-19","paymentDate":"2015-06-30","value":1.0397119,"currency":"USD"},{"executeDate":"2017-04-25","recordDate":"2017-04-27","paymentDate":"2017-05-08","value":0.160581,"currency":"USD"},{"executeDate":"2018-04-17","recordDate":"2018-04-18","paymentDate":"2018-04-27","value":0.605505,"currency":"USD"},{"executeDate":"2019-04-23","recordDate":"2019-04-24","paymentDate":"2019-05-03","value":1.0849538,"currency":"USD"},{"executeDate":"2019-12-26","recordDate":"2019-12-27","paymentDate":"2020-01-02","value":0.4861737,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0909,"buy":0,"hold":0.5455,"sell":0.2727,"strongSell":0.0909,"meanLabel":"HOLD","meanPercent":0.5455,"analysts":11,"updateTime":1739851200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EC","date":"2025-05-06","current":4.6665,"percent":0.314634,"low":2.588919,"twenty":3.863076,"median":5.327243,"eighty":12.825744,"high":64.266012,"avg":9.852124,"sd":11.444531,"marketCap":16180534337.75},"quantilePoints":[{"date":"2020-05-08","current":6.102881,"twenty":-8.115955,"median":10.415218,"eighty":13.778662,"marketCap":21658246531.61},{"date":"2020-05-15","current":7.128331,"twenty":-8.115955,"median":10.390367,"eighty":13.778662,"marketCap":20193195773.75},{"date":"2020-05-22","current":7.276069,"twenty":-8.115955,"median":10.372727,"eighty":13.733732,"marketCap":21421174870.89},{"date":"2020-05-29","current":7.349937,"twenty":-8.115955,"median":10.362824,"eighty":13.714284,"marketCap":22056885495.23},{"date":"2020-06-05","current":8.661107,"twenty":-8.115955,"median":10.344145,"eighty":13.709422,"marketCap":27085411834.39},{"date":"2020-06-12","current":7.848551,"twenty":-8.115955,"median":10.319805,"eighty":13.699296,"marketCap":23200471645.31},{"date":"2020-06-19","current":7.903953,"twenty":-8.092431,"median":10.300132,"eighty":13.688426,"marketCap":23609994267.63},{"date":"2020-06-26","current":7.645412,"twenty":-8.08655,"median":10.287946,"eighty":13.686342,"marketCap":22623417242.58},{"date":"2020-07-02","current":7.682347,"twenty":-8.08655,"median":10.273776,"eighty":13.686342,"marketCap":23374528521.7},{"date":"2020-07-10","current":7.682347,"twenty":-8.08655,"median":10.231601,"eighty":13.672495,"marketCap":23632243210.7},{"date":"2020-07-17","current":8.199428,"twenty":-8.08655,"median":10.199864,"eighty":13.663263,"marketCap":25086314025.12},{"date":"2020-07-24","current":8.199428,"twenty":-8.068906,"median":10.178679,"eighty":13.650092,"marketCap":24734192014.9},{"date":"2020-07-31","current":7.682347,"twenty":-8.057144,"median":10.111782,"eighty":13.640634,"marketCap":22930803559.42},{"date":"2020-08-07","current":11.632318,"twenty":-8.057144,"median":10.172576,"eighty":13.640183,"marketCap":23832899932.5},{"date":"2020-08-14","current":11.793133,"twenty":-8.057144,"median":10.192421,"eighty":13.629769,"marketCap":23903159981.5},{"date":"2020-08-21","current":11.685923,"twenty":-8.057144,"median":10.231601,"eighty":13.619393,"marketCap":23443635095.52},{"date":"2020-08-28","current":11.65912,"twenty":-8.057144,"median":10.270329,"eighty":13.617103,"marketCap":23779198827.58},{"date":"2020-09-04","current":11.498305,"twenty":-8.057144,"median":10.284523,"eighty":13.609447,"marketCap":23776806974.38},{"date":"2020-09-11","current":10.855043,"twenty":-8.057144,"median":10.291369,"eighty":13.600215,"marketCap":22417626544.05},{"date":"2020-09-18","current":11.337489,"twenty":-8.057144,"median":10.314383,"eighty":13.584791,"marketCap":23327291308.61},{"date":"2020-09-25","current":10.292189,"twenty":-8.057144,"median":10.319805,"eighty":13.561711,"marketCap":20378443894.99},{"date":"2020-10-02","current":10.238584,"twenty":-8.057144,"median":10.314383,"eighty":13.538631,"marketCap":20154725229.8},{"date":"2020-10-09","current":10.388678,"twenty":-8.057144,"median":10.308961,"eighty":13.478624,"marketCap":20836271816.86},{"date":"2020-10-16","current":10.077768,"twenty":-8.057144,"median":10.29616,"eighty":13.39092,"marketCap":20097076675.56},{"date":"2020-10-23","current":9.970558,"twenty":-8.057144,"median":10.291369,"eighty":13.344761,"marketCap":20240056139.58},{"date":"2020-10-30","current":13.354362,"twenty":-8.045382,"median":10.291779,"eighty":13.339443,"marketCap":19098996340.43},{"date":"2020-11-06","current":13.66753,"twenty":-8.027739,"median":10.300132,"eighty":13.478624,"marketCap":20189365488.02},{"date":"2020-11-13","current":14.912744,"twenty":-8.027739,"median":10.319805,"eighty":13.590618,"marketCap":22610846979.57},{"date":"2020-11-20","current":16.053569,"twenty":-8.027739,"median":10.344145,"eighty":13.620537,"marketCap":24261858653.1},{"date":"2020-11-27","current":16.19524,"twenty":-8.027739,"median":10.361737,"eighty":13.641085,"marketCap":24731503978.59},{"date":"2020-12-04","current":16.500951,"twenty":-8.027739,"median":10.372727,"eighty":13.68258,"marketCap":26223772364.1},{"date":"2020-12-11","current":17.224219,"twenty":-8.027739,"median":10.388678,"eighty":13.70689,"marketCap":27667442900.73},{"date":"2020-12-18","current":17.343521,"twenty":-8.027739,"median":10.399188,"eighty":13.778662,"marketCap":27962526123.89},{"date":"2020-12-24","current":17.052723,"twenty":-8.027739,"median":10.415218,"eighty":13.826153,"marketCap":26881415841.75},{"date":"2020-12-31","current":16.739555,"twenty":-8.027739,"median":10.428877,"eighty":13.864693,"marketCap":26994291439.99},{"date":"2021-01-08","current":17.887837,"twenty":-8.027739,"median":10.443632,"eighty":13.884097,"marketCap":28336383384.46},{"date":"2021-01-15","current":18.04442,"twenty":-8.004214,"median":10.45629,"eighty":13.94086,"marketCap":28718079297.45},{"date":"2021-01-22","current":17.5523,"twenty":-7.998333,"median":10.472905,"eighty":13.9633,"marketCap":27428996316},{"date":"2021-01-29","current":15.136435,"twenty":-7.998333,"median":10.484881,"eighty":13.996226,"marketCap":23416813550.86},{"date":"2021-02-05","current":16.068482,"twenty":-7.998333,"median":10.499343,"eighty":14.123084,"marketCap":25042104133.89},{"date":"2021-02-12","current":16.0312,"twenty":-7.998333,"median":10.512522,"eighty":14.180251,"marketCap":25204109478.1},{"date":"2021-02-19","current":16.143045,"twenty":-7.986571,"median":10.513852,"eighty":14.217179,"marketCap":25046465773.01},{"date":"2021-02-26","current":58.305857,"twenty":-7.968927,"median":10.548119,"eighty":14.277186,"marketCap":25507337685.76},{"date":"2021-03-05","current":62.192915,"twenty":-7.968927,"median":10.549134,"eighty":14.309498,"marketCap":27185340438.03},{"date":"2021-03-12","current":61.622813,"twenty":-7.968927,"median":10.55525,"eighty":14.383353,"marketCap":27404215357.16},{"date":"2021-03-19","current":61.415503,"twenty":-7.968927,"median":10.560215,"eighty":14.424897,"marketCap":27381860856.27},{"date":"2021-03-26","current":60.923143,"twenty":-7.968927,"median":10.566774,"eighty":14.471057,"marketCap":26275612062.35},{"date":"2021-04-01","current":61.311848,"twenty":-7.968927,"median":10.569887,"eighty":14.506881,"marketCap":26583440261.39},{"date":"2021-04-09","current":58.564995,"twenty":-7.963046,"median":10.584415,"eighty":14.560475,"marketCap":25527094664.96},{"date":"2021-04-16","current":59.627457,"twenty":-7.939522,"median":10.587425,"eighty":14.602488,"marketCap":26281880793.85},{"date":"2021-04-23","current":57.735756,"twenty":-7.939522,"median":10.608026,"eighty":14.657491,"marketCap":25100144058.23},{"date":"2021-04-30","current":57.269309,"twenty":-7.939522,"median":10.61798,"eighty":14.744064,"marketCap":24302726735.73},{"date":"2021-05-07","current":20.722698,"twenty":-7.939522,"median":10.625618,"eighty":14.842782,"marketCap":25005315360.88},{"date":"2021-05-14","current":21.619353,"twenty":-7.933641,"median":10.625618,"eighty":15.002221,"marketCap":26643921768.12},{"date":"2021-05-21","current":20.695527,"twenty":-7.904235,"median":10.640622,"eighty":15.167685,"marketCap":25157084391.01},{"date":"2021-05-28","current":20.025299,"twenty":-7.88071,"median":10.65789,"eighty":15.365348,"marketCap":24472773564.38},{"date":"2021-06-04","current":21.329525,"twenty":-7.88071,"median":10.669598,"eighty":15.402274,"marketCap":26866573068.16},{"date":"2021-06-11","current":21.655582,"twenty":-7.88071,"median":10.685426,"eighty":15.557539,"marketCap":27175480153.64},{"date":"2021-06-18","current":21.709924,"twenty":-7.88071,"median":10.704782,"eighty":15.583818,"marketCap":26245397627.8},{"date":"2021-06-25","current":25.088231,"twenty":-7.88071,"median":10.720006,"eighty":15.743857,"marketCap":30460069078.47},{"date":"2021-07-02","current":25.821858,"twenty":-7.851305,"median":10.727521,"eighty":15.919354,"marketCap":31007458421.16},{"date":"2021-07-09","current":25.006717,"twenty":-7.804255,"median":10.758908,"eighty":15.993918,"marketCap":29565641596.76},{"date":"2021-07-16","current":23.186235,"twenty":-7.792493,"median":10.78369,"eighty":16.056552,"marketCap":27597991192.03},{"date":"2021-07-23","current":23.104721,"twenty":1.744237,"median":10.795303,"eighty":16.096961,"marketCap":27080627944.38},{"date":"2021-07-30","current":23.847405,"twenty":4.224151,"median":10.801539,"eighty":16.246916,"marketCap":28048152007.56},{"date":"2021-08-06","current":12.710961,"twenty":4.403647,"median":10.812794,"eighty":16.246916,"marketCap":26445510448.34},{"date":"2021-08-13","current":12.905593,"twenty":4.442538,"median":10.823748,"eighty":16.240705,"marketCap":27744434941.12},{"date":"2021-08-20","current":12.656065,"twenty":4.657934,"median":10.823748,"eighty":16.204333,"marketCap":26967345402.64},{"date":"2021-08-27","current":13.274894,"twenty":4.807514,"median":10.828241,"eighty":16.153484,"marketCap":28519011180.03},{"date":"2021-09-03","current":13.15013,"twenty":5.094709,"median":10.857136,"eighty":16.096961,"marketCap":28507430734.94},{"date":"2021-09-10","current":12.740904,"twenty":5.313096,"median":10.873763,"eighty":16.08544,"marketCap":27364682362.77},{"date":"2021-09-17","current":12.805782,"twenty":5.45071,"median":10.889499,"eighty":16.079739,"marketCap":27601161170.58},{"date":"2021-09-24","current":12.725933,"twenty":5.492593,"median":10.924728,"eighty":16.071464,"marketCap":27244457816.11},{"date":"2021-10-01","current":13.818866,"twenty":5.504559,"median":10.92749,"eighty":16.059534,"marketCap":30101294872.59},{"date":"2021-10-08","current":14.512554,"twenty":5.540458,"median":10.942084,"eighty":16.040148,"marketCap":31766032985.79},{"date":"2021-10-15","current":14.772063,"twenty":5.636189,"median":10.962071,"eighty":16.008831,"marketCap":32297167497.92},{"date":"2021-10-22","current":14.422724,"twenty":5.69303,"median":10.9698,"eighty":15.993918,"marketCap":31388448015.98},{"date":"2021-10-29","current":14.208129,"twenty":5.707988,"median":10.982384,"eighty":15.993918,"marketCap":30938584888.05},{"date":"2021-11-05","current":14.357846,"twenty":5.731921,"median":11.005297,"eighty":15.971549,"marketCap":30508260850.86},{"date":"2021-11-12","current":10.821451,"twenty":5.779787,"median":10.996652,"eighty":15.934267,"marketCap":30028393272.71},{"date":"2021-11-19","current":10.078429,"twenty":5.80372,"median":10.978125,"eighty":15.919354,"marketCap":27735497042.93},{"date":"2021-11-26","current":9.663099,"twenty":5.815686,"median":10.9698,"eighty":15.901459,"marketCap":25946683687.22},{"date":"2021-12-03","current":10.139395,"twenty":5.833636,"median":10.962253,"eighty":15.859703,"marketCap":27663402839.39},{"date":"2021-12-10","current":10.314672,"twenty":5.833636,"median":10.946258,"eighty":15.825404,"marketCap":28555311336.09},{"date":"2021-12-17","current":10.078429,"twenty":5.845602,"median":10.937911,"eighty":15.782048,"marketCap":27314059035.32},{"date":"2021-12-23","current":10.097481,"twenty":5.872527,"median":10.92749,"eighty":15.71334,"marketCap":27258209523.55},{"date":"2021-12-31","current":10.249896,"twenty":5.911418,"median":10.917433,"eighty":15.590738,"marketCap":27187431472.42},{"date":"2022-01-07","current":10.101291,"twenty":5.926376,"median":10.889499,"eighty":15.588592,"marketCap":26932288402.65},{"date":"2022-01-14","current":10.672847,"twenty":5.941334,"median":10.873763,"eighty":15.587637,"marketCap":28758892730.03},{"date":"2022-01-21","current":10.863365,"twenty":5.9533,"median":10.875619,"eighty":15.583818,"marketCap":29601943576.06},{"date":"2022-01-28","current":10.996728,"twenty":6.102881,"median":10.889499,"eighty":15.583818,"marketCap":29787077559.89},{"date":"2022-02-04","current":11.053884,"twenty":6.177671,"median":10.911516,"eighty":15.557539,"marketCap":30226428284.35},{"date":"2022-02-11","current":11.32442,"twenty":6.204595,"median":10.924728,"eighty":15.557539,"marketCap":31213777266},{"date":"2022-02-18","current":11.419679,"twenty":6.264427,"median":10.942084,"eighty":15.557539,"marketCap":31437797276.81},{"date":"2022-02-25","current":11.674974,"twenty":6.719152,"median":10.966026,"eighty":15.557539,"marketCap":32235185643.05},{"date":"2022-03-04","current":8.775545,"twenty":7.060195,"median":10.9698,"eighty":15.557539,"marketCap":35993542030.87},{"date":"2022-03-11","current":8.93319,"twenty":7.246521,"median":10.9698,"eighty":15.557539,"marketCap":36596969016.47},{"date":"2022-03-18","current":8.591626,"twenty":7.364711,"median":10.9698,"eighty":15.557539,"marketCap":35253970222.95},{"date":"2022-03-25","current":9.432397,"twenty":7.512449,"median":10.9698,"eighty":15.557539,"marketCap":38980889412.18},{"date":"2022-04-01","current":9.274753,"twenty":7.608478,"median":10.9698,"eighty":15.557539,"marketCap":38450231073.35},{"date":"2022-04-08","current":9.379849,"twenty":7.682347,"median":10.9698,"eighty":15.557539,"marketCap":38840654118.15},{"date":"2022-04-14","current":8.79131,"twenty":7.734055,"median":10.9698,"eighty":15.557539,"marketCap":36814680340.58},{"date":"2022-04-22","current":8.814956,"twenty":7.848551,"median":10.9698,"eighty":15.557539,"marketCap":36083314330.36},{"date":"2022-04-29","current":8.423472,"twenty":7.937194,"median":10.9698,"eighty":15.557539,"marketCap":33232522355.71},{"date":"2022-05-06","current":8.612646,"twenty":8.036916,"median":10.9698,"eighty":15.557539,"marketCap":33355736677.76},{"date":"2022-05-13","current":6.665183,"twenty":8.103632,"median":10.9698,"eighty":15.557539,"marketCap":31053756069.43},{"date":"2022-05-20","current":6.100082,"twenty":8.103632,"median":10.9698,"eighty":15.557539,"marketCap":29215441427.83},{"date":"2022-05-27","current":6.443869,"twenty":8.103632,"median":10.9698,"eighty":15.557539,"marketCap":31633906458.52},{"date":"2022-06-03","current":7.09062,"twenty":8.103632,"median":10.9698,"eighty":15.557539,"marketCap":36015579040.45},{"date":"2022-06-10","current":6.768319,"twenty":8.103632,"median":10.9698,"eighty":15.557539,"marketCap":33175611750.38},{"date":"2022-06-17","current":5.930337,"twenty":8.103632,"median":10.9698,"eighty":15.557539,"marketCap":29053271209.52},{"date":"2022-06-24","current":4.596011,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21309510065.4},{"date":"2022-07-01","current":5.049381,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":23031543041.38},{"date":"2022-07-08","current":4.941947,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21588001138.43},{"date":"2022-07-15","current":4.507915,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":19716315930.61},{"date":"2022-07-22","current":4.426266,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":19171225427.54},{"date":"2022-07-29","current":4.898974,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21883856364.26},{"date":"2022-08-05","current":3.574458,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21338876009.71},{"date":"2022-08-12","current":3.730145,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":23041049912.2},{"date":"2022-08-19","current":3.601465,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21140719616.75},{"date":"2022-08-26","current":3.841351,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":22629951917.79},{"date":"2022-09-02","current":3.650713,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21012334466.97},{"date":"2022-09-09","current":3.704727,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21967588896.88},{"date":"2022-09-16","current":3.65389,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21341487133.73},{"date":"2022-09-23","current":3.23131,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":18854575930.98},{"date":"2022-09-30","current":3.294856,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":18534639915.46},{"date":"2022-10-07","current":3.717436,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20860105711.81},{"date":"2022-10-14","current":3.431479,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":19210084039.28},{"date":"2022-10-21","current":3.738088,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":19779927748.93},{"date":"2022-10-28","current":3.828641,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20554935737.41},{"date":"2022-11-04","current":4.035166,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20491789367.72},{"date":"2022-11-11","current":3.24681,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20458414210.6},{"date":"2022-11-18","current":3.361163,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20337590990.79},{"date":"2022-11-25","current":3.344827,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20723664325.37},{"date":"2022-12-02","current":3.127012,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":19844314857.84},{"date":"2022-12-09","current":2.988155,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":18750367698.78},{"date":"2022-12-16","current":2.903751,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":18284182498.81},{"date":"2022-12-23","current":3.131096,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":19947772061.04},{"date":"2022-12-30","current":3.294457,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20529504239.87},{"date":"2023-01-06","current":3.602122,"twenty":7.977821,"median":10.962071,"eighty":15.448048,"marketCap":22389902276.09},{"date":"2023-01-13","current":3.694693,"twenty":7.915033,"median":10.92749,"eighty":15.353601,"marketCap":23782172411.38},{"date":"2023-01-20","current":3.74234,"twenty":7.848551,"median":10.9129,"eighty":15.15206,"marketCap":24396148087.2},{"date":"2023-01-27","current":3.549029,"twenty":7.730361,"median":10.871907,"eighty":14.912744,"marketCap":23576646443.82},{"date":"2023-02-03","current":3.453735,"twenty":7.67496,"median":10.855043,"eighty":14.784787,"marketCap":22203715289.17},{"date":"2023-02-10","current":3.578979,"twenty":7.608478,"median":10.823748,"eighty":14.726178,"marketCap":22573097153.72},{"date":"2023-02-17","current":3.452374,"twenty":7.460741,"median":10.819131,"eighty":14.657544,"marketCap":21286938129.56},{"date":"2023-02-24","current":3.566727,"twenty":7.361018,"median":10.801539,"eighty":14.626454,"marketCap":22170808225.69},{"date":"2023-03-03","current":3.545128,"twenty":7.216974,"median":10.78369,"eighty":14.586838,"marketCap":23427703717.77},{"date":"2023-03-10","current":3.317459,"twenty":7.088595,"median":10.7295,"eighty":14.524941,"marketCap":22187614317.96},{"date":"2023-03-17","current":3.122315,"twenty":7.0094,"median":10.713578,"eighty":14.500509,"marketCap":20406573454.93},{"date":"2023-03-24","current":2.988315,"twenty":6.781898,"median":10.678394,"eighty":14.458692,"marketCap":19971462825.74},{"date":"2023-03-31","current":3.187363,"twenty":6.671286,"median":10.65789,"eighty":14.423159,"marketCap":21760504177.85},{"date":"2023-04-06","current":3.30445,"twenty":6.650793,"median":10.635059,"eighty":14.418662,"marketCap":22872624729},{"date":"2023-04-14","current":3.334372,"twenty":6.418945,"median":10.625618,"eighty":14.355658,"marketCap":23842101468.43},{"date":"2023-04-21","current":3.27843,"twenty":6.252461,"median":10.590434,"eighty":14.307221,"marketCap":22859238559.53},{"date":"2023-04-28","current":2.84651,"twenty":6.208833,"median":10.584415,"eighty":14.251173,"marketCap":19349032795.29},{"date":"2023-05-05","current":2.588919,"twenty":6.139878,"median":10.566774,"eighty":14.215464,"marketCap":17727705001.21},{"date":"2023-05-12","current":2.799899,"twenty":5.947317,"median":10.55525,"eighty":14.180251,"marketCap":18718310549.59},{"date":"2023-05-19","current":2.830711,"twenty":5.851586,"median":10.547103,"eighty":14.107762,"marketCap":19231782153.84},{"date":"2023-05-26","current":2.794541,"twenty":5.779787,"median":10.513852,"eighty":14.036335,"marketCap":19186073980.7},{"date":"2023-06-02","current":2.765068,"twenty":5.636189,"median":10.502473,"eighty":13.996226,"marketCap":19252463212.38},{"date":"2023-06-09","current":2.908412,"twenty":5.338256,"median":10.484881,"eighty":13.941499,"marketCap":21397594307.35},{"date":"2023-06-16","current":2.884224,"twenty":4.96902,"median":10.443632,"eighty":13.927233,"marketCap":21241570166.18},{"date":"2023-06-23","current":2.877526,"twenty":4.924758,"median":10.424038,"eighty":13.931562,"marketCap":21499710361.53},{"date":"2023-06-30","current":2.884224,"twenty":4.886941,"median":10.390367,"eighty":13.91118,"marketCap":21130530306.86},{"date":"2023-07-07","current":2.853413,"twenty":4.835802,"median":10.372727,"eighty":13.879481,"marketCap":20797568199.88},{"date":"2023-07-14","current":2.995414,"twenty":4.714842,"median":10.361737,"eighty":13.869409,"marketCap":22415987059.75},{"date":"2023-07-21","current":2.921734,"twenty":4.596011,"median":10.322954,"eighty":13.870981,"marketCap":22516260606.85},{"date":"2023-07-28","current":2.945847,"twenty":4.507915,"median":10.29616,"eighty":13.863121,"marketCap":23012958238.52},{"date":"2023-08-04","current":3.121339,"twenty":4.248084,"median":10.286261,"eighty":13.696764,"marketCap":23184235668.09},{"date":"2023-08-11","current":3.839397,"twenty":4.000076,"median":10.267916,"eighty":13.604343,"marketCap":23607572072.62},{"date":"2023-08-18","current":3.885026,"twenty":3.90194,"median":10.240429,"eighty":13.50446,"marketCap":23091698704.87},{"date":"2023-08-25","current":3.896866,"twenty":3.896866,"median":10.224768,"eighty":13.50446,"marketCap":23283897302.7},{"date":"2023-09-01","current":3.986507,"twenty":3.896866,"median":10.181829,"eighty":13.50446,"marketCap":23647467030.48},{"date":"2023-09-08","current":4.033865,"twenty":3.896866,"median":10.143425,"eighty":13.50446,"marketCap":24250288549.3},{"date":"2023-09-15","current":4.15395,"twenty":3.896866,"median":10.123411,"eighty":13.354362,"marketCap":25668539731.74},{"date":"2023-09-22","current":4.174247,"twenty":3.896866,"median":10.099573,"eighty":13.274894,"marketCap":25723339627.09},{"date":"2023-09-29","current":3.945915,"twenty":3.896866,"median":10.078098,"eighty":13.15013,"marketCap":23472544770.05},{"date":"2023-10-06","current":3.925618,"twenty":3.896866,"median":10.071608,"eighty":13.050319,"marketCap":21839950653.49},{"date":"2023-10-12","current":4.240209,"twenty":3.896866,"median":10.039952,"eighty":12.940527,"marketCap":24300899049.42},{"date":"2023-10-20","current":4.42964,"twenty":3.89593,"median":9.98317,"eighty":12.884329,"marketCap":25310163915.08},{"date":"2023-10-27","current":4.186086,"twenty":3.893123,"median":9.960618,"eighty":12.82556,"marketCap":24462456576.38},{"date":"2023-11-03","current":4.194543,"twenty":3.893123,"median":9.927672,"eighty":12.803786,"marketCap":25266844123.99},{"date":"2023-11-10","current":4.85945,"twenty":3.893123,"median":9.909277,"eighty":12.803786,"marketCap":23963749044.29},{"date":"2023-11-17","current":4.952503,"twenty":3.893123,"median":9.902932,"eighty":12.803786,"marketCap":24118759651.85},{"date":"2023-11-24","current":5.169817,"twenty":3.893123,"median":9.891721,"eighty":12.803786,"marketCap":25265887504.92},{"date":"2023-12-01","current":5.211175,"twenty":3.893123,"median":9.879822,"eighty":12.803786,"marketCap":25611546029.96},{"date":"2023-12-08","current":5.097439,"twenty":3.894059,"median":9.834565,"eighty":12.801789,"marketCap":25297686803.83},{"date":"2023-12-15","current":5.283553,"twenty":3.894059,"median":9.834565,"eighty":12.801789,"marketCap":26543991442.74},{"date":"2023-12-22","current":4.869967,"twenty":3.894059,"median":9.834565,"eighty":12.801789,"marketCap":24577966848.99},{"date":"2023-12-29","current":4.838949,"twenty":3.893123,"median":9.836153,"eighty":12.803786,"marketCap":25178756823.67},{"date":"2024-01-05","current":4.973364,"twenty":3.892187,"median":9.837742,"eighty":12.805782,"marketCap":25160462757.48},{"date":"2024-01-12","current":4.869967,"twenty":3.892187,"median":9.837742,"eighty":12.805782,"marketCap":24641765108.78},{"date":"2024-01-19","current":4.756231,"twenty":3.892187,"median":9.844654,"eighty":12.807778,"marketCap":24078522670.15},{"date":"2024-01-26","current":4.869967,"twenty":3.892187,"median":9.837742,"eighty":12.805782,"marketCap":24572977032.09},{"date":"2024-02-02","current":4.849288,"twenty":3.892187,"median":9.837742,"eighty":12.805782,"marketCap":24830968078.3},{"date":"2024-02-09","current":4.838949,"twenty":3.892187,"median":9.837742,"eighty":12.805782,"marketCap":24362672332.27},{"date":"2024-02-16","current":4.745892,"twenty":3.892187,"median":9.837742,"eighty":12.805782,"marketCap":24147298816.1},{"date":"2024-02-23","current":4.838949,"twenty":3.892187,"median":9.834565,"eighty":12.805782,"marketCap":24431341401.84},{"date":"2024-03-01","current":4.939525,"twenty":3.893123,"median":9.737218,"eighty":12.803786,"marketCap":23952488130.27},{"date":"2024-03-08","current":4.508126,"twenty":3.893123,"median":9.70238,"eighty":12.803786,"marketCap":21947666113.83},{"date":"2024-03-15","current":4.572814,"twenty":3.893123,"median":9.667099,"eighty":12.803786,"marketCap":22370689783.86},{"date":"2024-03-22","current":4.583599,"twenty":3.893123,"median":9.548009,"eighty":12.778323,"marketCap":22474207427.59},{"date":"2024-03-28","current":4.475749,"twenty":3.893123,"median":9.466237,"eighty":12.778323,"marketCap":22089724123.39},{"date":"2024-04-05","current":5.004211,"twenty":3.892187,"median":9.402489,"eighty":12.787678,"marketCap":25269737391.93},{"date":"2024-04-12","current":4.874792,"twenty":3.892187,"median":9.295772,"eighty":12.787678,"marketCap":24296961694.18},{"date":"2024-04-19","current":4.799298,"twenty":3.892187,"median":9.274753,"eighty":12.787678,"marketCap":23301659582.09},{"date":"2024-04-26","current":4.971857,"twenty":3.893123,"median":9.175126,"eighty":12.778323,"marketCap":23960050881.17},{"date":"2024-05-03","current":4.864007,"twenty":3.893123,"median":8.95412,"eighty":12.778323,"marketCap":23752567318.04},{"date":"2024-05-10","current":5.383345,"twenty":3.893123,"median":8.867182,"eighty":12.778323,"marketCap":24064602087.79},{"date":"2024-05-17","current":5.430568,"twenty":3.893123,"median":8.795251,"eighty":12.778323,"marketCap":24652224339.04},{"date":"2024-05-24","current":5.418762,"twenty":3.893123,"median":8.740075,"eighty":12.778323,"marketCap":24601197777.08},{"date":"2024-05-31","current":5.548903,"twenty":3.893123,"median":8.682856,"eighty":12.778323,"marketCap":24948806455.5},{"date":"2024-06-07","current":5.584322,"twenty":3.893123,"median":8.59294,"eighty":12.778323,"marketCap":24693614094.28},{"date":"2024-06-14","current":5.678771,"twenty":3.892187,"median":8.439501,"eighty":12.787678,"marketCap":23998459101.92},{"date":"2024-06-21","current":5.501679,"twenty":3.892187,"median":8.381434,"eighty":12.789302,"marketCap":22878611698.83},{"date":"2024-06-28","current":5.489873,"twenty":3.892187,"median":8.310231,"eighty":12.794176,"marketCap":22954501069.55},{"date":"2024-07-05","current":5.383617,"twenty":3.892187,"median":8.217895,"eighty":12.794176,"marketCap":22901200413.63},{"date":"2024-07-12","current":5.289168,"twenty":3.892187,"median":8.13183,"eighty":12.794176,"marketCap":23204604596.91},{"date":"2024-07-15","current":5.171106,"twenty":3.892187,"median":8.107092,"eighty":12.794176,"marketCap":22824658784.59},{"date":"2024-08-02","current":5.005819,"twenty":3.876246,"median":7.931653,"eighty":12.819755,"marketCap":21485677284.4},{"date":"2024-08-09","current":4.923176,"twenty":3.876246,"median":7.848551,"eighty":12.819755,"marketCap":20886419400.33},{"date":"2024-08-16","current":5.133096,"twenty":3.876246,"median":7.728514,"eighty":12.819755,"marketCap":21386096998.62},{"date":"2024-08-23","current":5.009826,"twenty":3.876246,"median":7.673113,"eighty":12.819755,"marketCap":20566937957.91},{"date":"2024-08-30","current":5.034444,"twenty":3.876246,"median":7.608478,"eighty":12.819755,"marketCap":20378972525.7},{"date":"2024-09-06","current":4.739024,"twenty":3.876246,"median":7.506908,"eighty":12.819755,"marketCap":18940304213.61},{"date":"2024-09-13","current":4.751333,"twenty":3.876246,"median":7.359171,"eighty":12.819755,"marketCap":18705266064.42},{"date":"2024-09-20","current":4.689788,"twenty":3.876246,"median":7.2022,"eighty":12.819755,"marketCap":18729179929.81},{"date":"2024-09-27","current":4.677478,"twenty":3.876246,"median":7.088216,"eighty":12.819755,"marketCap":18693431578.81},{"date":"2024-10-04","current":4.689788,"twenty":3.876246,"median":7.005747,"eighty":12.819755,"marketCap":18661799148.11},{"date":"2024-10-11","current":4.542078,"twenty":3.876246,"median":6.779635,"eighty":12.819755,"marketCap":17972116015.88},{"date":"2024-10-18","current":4.283586,"twenty":3.876246,"median":6.671286,"eighty":12.819755,"marketCap":16817039340.09},{"date":"2024-10-25","current":4.258967,"twenty":3.876246,"median":6.623283,"eighty":12.819755,"marketCap":16507746997.84},{"date":"2024-10-31","current":4.234349,"twenty":3.876246,"median":6.412714,"eighty":12.819755,"marketCap":16032080809.48},{"date":"2024-11-08","current":4.086639,"twenty":3.871856,"median":6.252461,"eighty":12.821752,"marketCap":15687984275.04},{"date":"2024-11-15","current":4.646307,"twenty":3.871856,"median":6.207587,"eighty":12.821752,"marketCap":15845911157.34},{"date":"2024-11-22","current":4.84832,"twenty":3.871856,"median":6.102881,"eighty":12.821752,"marketCap":16898815061.19},{"date":"2024-11-29","current":4.794465,"twenty":3.871856,"median":5.9533,"eighty":12.821752,"marketCap":16560180234.91},{"date":"2024-12-06","current":4.76753,"twenty":3.871856,"median":5.863552,"eighty":12.821752,"marketCap":16531483452.13},{"date":"2024-12-13","current":4.888738,"twenty":3.871856,"median":5.80372,"eighty":12.821752,"marketCap":17216536903.6},{"date":"2024-12-20","current":4.525113,"twenty":3.871856,"median":5.699013,"eighty":12.821752,"marketCap":15739882212.82},{"date":"2024-12-27","current":4.471243,"twenty":3.871856,"median":5.666965,"eighty":12.821752,"marketCap":15580193842.54},{"date":"2025-01-03","current":4.834868,"twenty":3.871856,"median":5.596128,"eighty":12.821752,"marketCap":16773742492.85},{"date":"2025-01-10","current":4.888738,"twenty":3.867466,"median":5.572516,"eighty":12.823748,"marketCap":17240401252.68},{"date":"2025-01-17","current":5.036882,"twenty":3.867466,"median":5.525012,"eighty":12.823748,"marketCap":17692127998.87},{"date":"2025-01-24","current":4.780998,"twenty":3.867466,"median":5.495776,"eighty":12.823748,"marketCap":17203435182.51},{"date":"2025-01-31","current":5.454377,"twenty":3.867466,"median":5.476216,"eighty":12.823748,"marketCap":19996471191.52},{"date":"2025-02-07","current":5.387039,"twenty":3.867466,"median":5.430705,"eighty":12.823748,"marketCap":19814319642.43},{"date":"2025-02-14","current":5.642924,"twenty":3.867466,"median":5.419036,"eighty":12.823748,"marketCap":20806134000.52},{"date":"2025-02-21","current":6.020017,"twenty":3.867466,"median":5.419036,"eighty":12.823748,"marketCap":22526244057.4},{"date":"2025-02-28","current":5.521715,"twenty":3.867466,"median":5.419036,"eighty":12.823748,"marketCap":20445151021.05},{"date":"2025-03-07","current":5.506086,"twenty":3.863076,"median":5.395151,"eighty":12.825744,"marketCap":20009097615.46},{"date":"2025-03-14","current":5.533616,"twenty":3.863076,"median":5.395151,"eighty":12.825744,"marketCap":20124812820.07},{"date":"2025-03-21","current":5.781504,"twenty":3.863076,"median":5.430568,"eighty":12.825744,"marketCap":20608888189.85},{"date":"2025-03-28","current":5.987986,"twenty":3.863076,"median":5.451025,"eighty":12.825744,"marketCap":21549111072.47},{"date":"2025-04-04","current":5.506194,"twenty":3.863076,"median":5.451025,"eighty":12.825744,"marketCap":19860259232.96},{"date":"2025-04-11","current":4.914279,"twenty":3.867466,"median":5.419036,"eighty":12.823748,"marketCap":16779063126.51},{"date":"2025-04-17","current":5.24465,"twenty":3.867466,"median":5.387039,"eighty":12.823748,"marketCap":18166222924.7},{"date":"2025-04-25","current":5.065699,"twenty":3.863076,"median":5.359734,"eighty":12.825744,"marketCap":17692043924.42},{"date":"2025-05-02","current":4.749093,"twenty":3.863076,"median":5.341009,"eighty":12.825744,"marketCap":16641162417.65},{"date":"2025-05-06","current":4.6665,"twenty":3.863076,"median":5.327243,"eighty":12.825744,"marketCap":16180534337.75}],"updateTime":1746620978297}}}